Explore more publications!
Mauritius Healthcare Daily
Got News to Share?

Mauritius Healthcare Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mauritius Healthcare Daily.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on April 23, 2026

Aurora Spine Corporation Schedules Release of Fourth Quarter and Fiscal 2025 Financial Results
Apr. 23, 2026

Aurora Spine Corporation Schedules Release of Fourth Quarter and Fiscal 2025 Financial Results

Indeterminate GlobeNewswire
The Joint Corp. to Report 2026 First Quarter Results on Thursday, May 7 and Host Conference Call and Webcast
Apr. 23, 2026

The Joint Corp. to Report 2026 First Quarter Results on Thursday, May 7 and Host Conference Call and Webcast

Indeterminate GlobeNewswire
Ocugen to Present at April 2026 Investor and Industry Conferences
Apr. 23, 2026

Ocugen to Present at April 2026 Investor and Industry Conferences

Indeterminate GlobeNewswire
Radiopharm Theranostics Reports Business Update
Apr. 23, 2026

Radiopharm Theranostics Reports Business Update

Indeterminate GlobeNewswire
Genenta signs Definitive Agreements with Sophia High Tech
Apr. 23, 2026

Genenta signs Definitive Agreements with Sophia High Tech

Indeterminate GlobeNewswire
Antag Therapeutics to present data on AT7687, its first-in-class GIPR antagonist peptide at the American Diabetes Association’s 2026 Scientific Sessions
Apr. 23, 2026

Antag Therapeutics to present data on AT7687, its first-in-class GIPR antagonist peptide at the American Diabetes Association’s 2026 Scientific Sessions

Indeterminate GlobeNewswire
Kymera Therapeutics to Report First Quarter 2026 Financial Results on April 30, 2026
Apr. 23, 2026

Kymera Therapeutics to Report First Quarter 2026 Financial Results on April 30, 2026

Indeterminate GlobeNewswire
Tonix Pharmaceuticals Presents Updates on Preclinical Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2026
Apr. 23, 2026

Tonix Pharmaceuticals Presents Updates on Preclinical Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2026

Indeterminate GlobeNewswire
AAFA Highlights New Resources for Nasal Polyps in Recognition of Global CRSwNP Awareness Day
Apr. 23, 2026

AAFA Highlights New Resources for Nasal Polyps in Recognition of Global CRSwNP Awareness Day

Indeterminate GlobeNewswire
Conavi Medical Awarded 2026 TAG Innovation Award
Apr. 23, 2026

Conavi Medical Awarded 2026 TAG Innovation Award

Indeterminate GlobeNewswire
Jade Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Apr. 23, 2026

Jade Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Psyence BioMed Initiates Patient Dosing in Phase IIb Trial Evaluating NPX-5 for Adjustment Disorder
Apr. 23, 2026

Psyence BioMed Initiates Patient Dosing in Phase IIb Trial Evaluating NPX-5 for Adjustment Disorder

Indeterminate GlobeNewswire
Verano Expands Retail Presence on Florida’s Emerald Coast with Opening of MÜV Miramar Beach, the Company’s 85th Florida Dispensary and 162nd Location Nationwide
Apr. 23, 2026

Verano Expands Retail Presence on Florida’s Emerald Coast with Opening of MÜV Miramar Beach, the Company’s 85th Florida Dispensary and 162nd Location Nationwide

Indeterminate GlobeNewswire
BrewDog USA Doubles Down on Headliners and Ignites Next Wave of Innovation for Spring and Summer
Apr. 23, 2026

BrewDog USA Doubles Down on Headliners and Ignites Next Wave of Innovation for Spring and Summer

Indeterminate GlobeNewswire
Validic Launches Free Developer Tier with API-Driven, Agentic-Ready Self-Signup
Apr. 23, 2026

Validic Launches Free Developer Tier with API-Driven, Agentic-Ready Self-Signup

Indeterminate GlobeNewswire
Transcenta Therapeutics Presents New Data for its Novel LIV1-Targeting ADC TST013 Demonstrating Potent Anti-Tumor Activity in PDX Models of Prostate Cancer and ER Positive /HER2 Negative Breast Cancer
Apr. 23, 2026

Transcenta Therapeutics Presents New Data for its Novel LIV1-Targeting ADC TST013 Demonstrating Potent Anti-Tumor Activity in PDX Models of Prostate Cancer and ER Positive /HER2 Negative Breast Cancer

Indeterminate GlobeNewswire
AAVantgarde to Participate in ARVO 2026, with Presentations at Key Pre-events and New Clinical Data from the LUCE Phase 1/2 Study
Apr. 23, 2026

AAVantgarde to Participate in ARVO 2026, with Presentations at Key Pre-events and New Clinical Data from the LUCE Phase 1/2 Study

Indeterminate GlobeNewswire
Aveanna Announces First Quarter 2026 Earnings Release Date and Conference Call
Apr. 23, 2026

Aveanna Announces First Quarter 2026 Earnings Release Date and Conference Call

Indeterminate GlobeNewswire
Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026
Apr. 23, 2026

Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026

Indeterminate GlobeNewswire
Epitopea Announces Approval of OVACT Clinical Trial Application for CryptiVax-1001 in Advanced High-Grade Serous Ovarian Cancer
Apr. 23, 2026

Epitopea Announces Approval of OVACT Clinical Trial Application for CryptiVax-1001 in Advanced High-Grade Serous Ovarian Cancer

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions